BioPharmSignal logoBioPharmSignal

Biotech News

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

Artivion (AORT)ArtivionFDA / regulatory

Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissections ATLANTA, April 7, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today

Open original release

Related news

AORTArtivion2026-03-03 21:10 EST

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

AORTArtivion2026-05-18 11:00 EST

Artivion Completes Acquisition of Endospan Ltd.

BSXBoston Scientific2026-03-30 10:45 EST

Boston Scientific receives FDA clearance for the Asurys™ Fluid Management System

DNLIDenali Therapeutics2026-03-25 15:50 EST

Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)

HYPRHyperfine2026-05-26 12:15 EST

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

ICCMIceCure Medical2026-03-11 12:30 EST

U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer

ICCMIceCure Medical2026-07-06 12:11 EST

IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer

ANGOAngioDynamics2026-05-27 12:30 EST

AngioDynamics to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ANGOAngioDynamics2026-05-13 13:00 EST

AngioDynamics Announces Two-Year PRESERVE Trial Data Demonstrating Durable NanoKnife IRE System Outcomes in Intermediate-Risk Prostate Cancer

XTNTXtant Medical2026-05-06 12:00 EST

Xtant Medical Expands Trivium™ Portfolio with the Commercial Launch of Trivium™ Shaped

View all latest news

Artivion

Artivion is a medical device company focused on cardiovascular surgery, aortic repair, and preservation technologies. Its products are used in complex cardiac and vascular procedures.

Recent company news

AORTArtivion2026-05-18 11:00 EST

Artivion Completes Acquisition of Endospan Ltd.

AORTArtivion2026-05-07 20:05 EST

Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan

AORTArtivion2026-04-23 20:15 EST

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2026 Financial Results

AORTArtivion2026-04-07 11:00 EST

Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

AORTArtivion2026-03-03 21:10 EST

Artivion to Participate in the Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Stock data

Close
26.10 USD
Market cap
991.26M USD
Exchange
NYSE
Sector
MedTech
Location
United States